Investors & Media

    Print Page     Close Window     

Overview

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT). Flex Pharma was founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Chair and CEO Christoph Westphal, M.D., Ph.D.

Stock Quote
FLKS (Common Stock)
Price & Exchange$4.57 (US Dollar)
NASDAQ GS
Change (%) Stock is Up 0.12 (2.70%)
Volume1,049,937
Data as of 06/23/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Upcoming EventsMore >>
There are currently no events scheduled.
Data Provided by Thomson Reuters